Hiroaki Ikeda

IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity

Vijay Shankaran, Hiroaki Ikeda, Allen T. Bruce et al. · Nature · 2001 · 2.8K citations

Lymphoid Neoplasia, Cancer Immunosurveillance, Lymphocyte Development +6

Eradication of Established Tumors by CD8+ T Cell Adoptive Immunotherapy

Holly L. Hanson, David L. Donermeyer, Hiroaki Ikeda et al. · Immunity · 2000 · 347 citations · Full text

Radiation Oncology, Tumor Immunology, Cell Therapy +12

Activated CD8+ T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells

Naohiro Seo, Yoshitaka Shirakura, Yoshiro Tahara et al. · Nature Communications · 2018 · 243 citations · Full text

Improved Expression and Reactivity of Transduced Tumor-Specific TCRs in Human Lymphocytes by Specific Silencing of Endogenous TCR

Sachiko Okamoto, Junichi Mineno, Hiroaki Ikeda et al. · Cancer Research · 2009 · 184 citations

Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal Cancer

Shinichi Kageyama, Hiroaki Ikeda, Yoshihiro Miyahara et al. · Clinical Cancer Research · 2015 · 176 citations